Steris | STE - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
3M USD 921M 140M 2026-09
Accuray USD 124.78M 2.54M 2025-12
Baxter International USD 730M 5M 2026-09
Becton, Dickinson and Co. USD 1.26B 1000K 2026-09
Boston Scientific USD 1.68B 120M 2026-09
CONMED USD 136.42M 9.14M 2026-09
Cooper Companies USD 401.3M 274.9M 2026-06
Dexcom USD 358.7M 9M 2026-06
Ecolab USD 1.18B 35.8M 2026-09
Edwards Lifesciences USD 560.9M 300K 2026-09
Fortive USD 406.5M 11.4M 2026-09
Getinge SEK 2.65B 452M 2024-12
Globus Medical USD 288.47M 1.65M 2026-09
Haemonetics USD 118.36M 580K 2026-09
Idexx Laboratories USD 293.13M 5.04M 2026-09
Inogen USD 43.77M 510K 2024-06
Insulet USD 350.7M 5.9M 2026-09
Integra LifeSciences USD 161.02M 5.2M 2026-09
Intuitive Surgical USD 1.08B 465.5M 2026-09
J&J USD 6.25B 168M 2026-09
Olympus JPY 126.1B 1.06B 2026-09
Orthofix International USD 130.35M 11.31M 2025-12
Owens Minor USD 258.98M 7.5M 2025-12
ResMed USD 290.65M 10.86M 2026-06
Steris USD 366M 3.7M 2026-09
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 113.94M 2.3M 2026-09
Teleflex USD 220.72M 7.21M 2026-09
Thermo Fisher Scientific USD 1.86B 46M 2026-09
Zimmer Biomet Holdings USD 855M 56.6M 2026-09